This information helps your healthcare provider gain a comprehensive understanding of your medical history and any potential interactions with the new treatment
Stratified by GLP-1 related and non GLP-1 related treatments In the included RCTs, GLP-1 related drugs (including liraglutide, semaglutide, beinaglutide, exenatide, and AMG133) showed significant weight regain compared with control group (WMD = 1.78 kg, 95% CI 0.76 to 2.80, P = 0.006, I 2 = 85%)
The use of any trade name or trademark is for identification and reference only and does not imply any endorsement, sponsorship, or affiliation by or with the trademark holder of their brand.
Parenteral drug products should be visually inspected for particulate matter and discoloration prior to administration, whenever the solution and container permit